 |
|
Second-Trimester Ultrasound to Detect Fetuses With Down Syndrome
A Meta-analysis
Rebecca Smith-Bindman, MD;
Wylie Hosmer, BS;
Vickie A. Feldstein, MD;
Jonathan J. Deeks, MSc;
James D. Goldberg, MD
JAMA. 2001;285:1044-1055.
Context Second-trimester prenatal ultrasound is widely used in an attempt to detect Down syndrome in fetuses, but the accuracy of this method is unknown.
Objective To determine the accuracy of second-trimester ultrasound in detecting Down syndrome in fetuses.
Data Sources English-language articles published between 1980 and February 1999 identified through MEDLINE and manual searches.
Study Selection Studies were included if they recorded second-trimester findings of ultrasonographic markers, chromosomal abnormalities, and clinical outcomes for a well-described sample of women. A total of 56 articles describing 1930 fetuses with Down syndrome and 130 365 unaffected fetuses were included.
Data Extraction Articles were independently reviewed, selected, and abstracted by 2 reviewers. Discrepancies in data abstraction were resolved by consensus with a third reviewer. Overall estimates of sensitivity, specificity, and positive and negative likelihood ratios were calculated for the following markers: choroid plexus cyst, thickened nuchal fold, echogenic intracardiac focus, echogenic bowel, renal pyelectasis, and humeral and femoral shortening. Results were stratified by whether markers were identified in isolation or in conjunction with fetal structural malformations.
Data Synthesis When ultrasonographic markers were observed without associated fetal structural malformations, sensitivity for each was low (range, 1%-16%), and most fetuses with such markers had normal outcomes. A thickened nuchal fold was the most accurate marker for discriminating between unaffected and affected fetuses and was associated with an approximately 17-fold increased risk of Down syndrome. If a thickened nuchal fold is used to screen for Down syndrome, 15 893 average-risk women or 6818 high-risk women would need to be screened for each case of Down syndrome identified. For each of the other 6 markers, when observed without associated structural malformations, the marker had marginal impact on the risk of Down syndrome. Because the markers were detected in only a small number of affected fetuses, the likelihood of Down syndrome did not decrease substantially after normal examination findings (none of the negative likelihood ratios were significant).
Conclusions A thickened nuchal fold in the second trimester may be useful in distinguishing unaffected fetuses from those with Down syndrome, but the overall sensitivity of this finding is too low for it to be a practical screening test for Down syndrome. When observed without associated structural malformations, the remaining ultrasonographic markers could not discriminate well between unaffected fetuses and those with Down syndrome. Using these markers as a basis for deciding to offer amniocentesis will result in more fetal losses than cases of Down syndrome detected, and will lead to a decrease in the prenatal detection of fetuses with Down syndrome.
Author Affiliations: Departments of Radiology (Drs Smith-Bindman and Feldstein and Mr Hosmer) and Epidemiology and Biostatistics (Dr Smith-Bindman), University of California, San Francisco; ICRF/NHS Centre for Statistics in Medicine, Institute of Health Sciences, University of Oxford, Oxford, England (Mr Deeks); and California Pacific Medical Center, San Francisco (Dr Goldberg).
RELATED LETTER
Ultrasound Markers of Fetal Down Syndrome
David A. Nyberg, James F. X. Egan, John F. Rodis, Peter A. Benn, Raymond O. Bahado-Singh, Inanc Mendilcioglu, Joshua Copel, Rebecca Smith-Bindman, and James D. Goldberg
JAMA. 2001;285(22):2856-2858.
EXTRACT
| FULL TEXT
RELATED ARTICLES
February 28, 2001
JAMA. 2001;285(8):1097-1098.
EXTRACT
| FULL TEXT
Down Syndrome
JAMA. 2001;285(8):1112.
PDF
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Correlation of Prenatal Sonographic Diagnosis and Morphologic Findings of Fetal Autopsy in Fetuses With Trisomy 21
Szigeti et al.
J Ultrasound Med 2007;26:61-68.
ABSTRACT
| FULL TEXT
Screening in women's health, with emphasis on fetal Down's syndrome, breast cancer and osteoporosis
Wildschut et al.
Hum Reprod Update 2006;12:499-512.
ABSTRACT
| FULL TEXT
Evidence of bias and variation in diagnostic accuracy studies.
Rutjes et al.
CMAJ 2006;174:469-476.
ABSTRACT
| FULL TEXT
Influence of Fetal Heart Orientation on the Sonographic Identification of an Echogenic Intracardiac Focus in the Left Ventricle
Fischer and Sveinbjornsson
Journal of Diagnostic Medical Sonography 2006;22:48-52.
ABSTRACT
Incorporating First-Trimester Down Syndrome Studies Into Prenatal Screening: Executive Summary of the National Institute of Child Health and Human Development Workshop
Reddy and Mennuti
Obstet Gynecol 2006;107:167-173.
ABSTRACT
| FULL TEXT
Echogenic Intracardiac Foci and Choroid Plexus Cysts * Reply
Filly et al.
J Ultrasound Med 2004;23:1135-1139.
FULL TEXT
Choroid Plexus Cyst and Echogenic Intracardiac Focus in Women at Low Risk for Chromosomal Anomalies: The Obligation to Inform the Mother
Doubilet et al.
J Ultrasound Med 2004;23:883-885.
FULL TEXT
An Isolated Echogenic Heart Focus Is Not an Indication for Amniocentesis in 12,672 Unselected Patients
Coco et al.
J Ultrasound Med 2004;23:489-496.
ABSTRACT
| FULL TEXT
Humerus Length Evaluation in Different Ethnic Groups
Mastrobattista et al.
J Ultrasound Med 2004;23:227-231.
ABSTRACT
| FULL TEXT
Combined Sonographic and Biochemical Markers for Down Syndrome Screening
Pinette et al.
J Ultrasound Med 2003;22:1185-1190.
ABSTRACT
| FULL TEXT
Echogenic Intracardiac Focus: Potential for Misdiagnosis
Winn et al.
J Ultrasound Med 2003;22:1207-1214.
ABSTRACT
| FULL TEXT
An ethical approach to giving couples information about their fetus
Boyle et al.
Hum Reprod 2003;18:2253-2256.
ABSTRACT
| FULL TEXT
AIUM Practice Guideline for the Performance of an Antepartum Obstetric Ultrasound Examination
J Ultrasound Med 2003;22:1116-1125.
FULL TEXT
Variation of Fetal Humeral Length in Second-Trimester Fetuses According to Race and Ethnicity
Zelop et al.
J Ultrasound Med 2003;22:691-693.
ABSTRACT
| FULL TEXT
Diagnostic Performance of Intracardiac Echogenic Foci for Down Syndrome: A Meta-analysis
Sotiriadis et al.
Obstet Gynecol 2003;101:1009-1016.
ABSTRACT
| FULL TEXT
An 8-Center Study to Evaluate the Utility of Midterm Genetic Sonograms Among High-Risk Pregnancies
Hobbins et al.
J Ultrasound Med 2003;22:33-38.
ABSTRACT
| FULL TEXT
Nasal Bone Evaluation in Fetuses With Down Syndrome During the Second and Third Trimesters of Pregnancy
Lee et al.
J Ultrasound Med 2003;22:55-60.
ABSTRACT
| FULL TEXT
Combined Second-Trimester Biochemical and Ultrasound Screening for Down Syndrome
Benn et al.
Obstet Gynecol 2002;100:1168-1176.
ABSTRACT
| FULL TEXT
The Genetic Sonogram: A Method of Risk Assessment for Down Syndrome in the Second Trimester
Bromley et al.
J Ultrasound Med 2002;21:1087-1096.
ABSTRACT
| FULL TEXT
Prenatal detection of cystic fibrosis by ultrasonography: a retrospective study of more than 346 000 pregnancies
Scotet et al.
J. Med. Genet. 2002;39:443-448.
FULL TEXT
Ultrasound Markers of Fetal Down Syndrome
Nyberg et al.
JAMA 2001;285:2856-2858.
FULL TEXT
|
